Skip to main content

Table 2 Adjusted association between fasting glucose and markers of glycaemia (HbA1c, glycated albumin and fructosamine)

From: The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study

 

HbA1c

Glycated albumin

Fructosamine

β

95% CI

p

β

95% CI

p

β

95% CI

p

Marker of glycaemia

1.52

1.47 to1.57

< 0.0001

0.46

0.44 to 0.47

< 0.0001

0.03

0.03 to 0.04

< 0.0001

Age

−0.04

−0.10 to − 0.01

0.105

− 0.03

−0.02 to 0.09

0.267

−0.03

− 0.10 to 0.10

0.539

Gender

0.05

−0.13 to 0.23

0.579

−0.32

−0.50 to − 0.13

0.001

−0.34

− 0.69 to 0.00

0.052

CKD

−1.22

−2.55 to 0.10

0.071

−1.00

−2.02 to 0.01

0.053

−0.09

−2.04 to 1.86

0.927

CKDxGM

0.21

0.02 to 0.39

0.030

0.05

−0.01 to 0.11

0.095

0.00

−0.01 to 0.01

0.815

Adjusted R2

0.72

0.73

0.67

  1. Data represents β-coefficients, 95% confidence interval, p-value and adjusted-R2
  2. CKD chronic kidney disease, CKDxGM interaction between CKD and the respective glycaemic marker, HbA1c haemoglobin A1c
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us